Posted on October 27, 202010/27/20
Canada Publishes Finalized PMPRB Guidelines Ahead of January 1, 2021 Implementation
Posted on October 22, 202010/22/20
Pricentric Insights: What a Biden Presidency Could Mean for Drug Pricing in the U.S.
Posted on October 20, 202010/20/20
UK’s MHRA Joins ACSS-Consortium, FDA’s Project Orbis
Posted on October 12, 202010/12/20
Japan’s Ministry of Health Proposes Finalized Off-Year Re-pricing for All Medicines
Posted on August 31, 20208/31/20
Cadila Launches Adalimumab Biosimilar, Cadalimab in India
Posted on August 19, 20208/19/20
China Publishes Working Plan for 2020 NRDL Update, Revised List Expected December 2020
Posted on August 10, 20208/10/20
Japan Outlines Measures to Ensure Stable Drug Supply
Posted on July 27, 20207/27/20
Trump Signs 4 Executive Orders on Prescription Drug Pricing
Posted on July 24, 20207/24/20
China’s 3rd Round of Volume-Based Procurement Includes 56 Drugs, 86 Product Specifications
Posted on July 22, 20207/22/20